NCT02339922 2026-03-05Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin LymphomaUniversity of WashingtonPhase 2 Active not recruiting33 enrolled 16 charts
NCT01939899 2019-10-29Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaTakedaPhase 2 Completed29 enrolled 26 charts